Urokinase - Effect on Surgery Plus Bcg for Bladder Cancer

Hudson, M'Liss Ann

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29CA054277-06
• Application #: 2095790
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Project Start: 1991-04-01
• Project End: 1997-03-31
• Budget Start: 1995-04-01
• Budget End: 1997-03-31
• Support Year: 6
• Fiscal Year: 1995

Institution

• Name: Washington University
• Department: Surgery
• Type: Schools of Medicine
• DUNS #: 062761671
• City: Saint Louis
• State: MO
• Country: United States
• Zip Code: 63130

Publications

Hudson, M A; McReynold, L M (1999) Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines. Adv Exp Med Biol 462:399-412

Hudson, M A; McReynolds, L M (1997) Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines. J Natl Cancer Inst 89:709-17